Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,241 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06561074RecruitingPhase 2
Study of calaspargase, decitabine, and venetoclax for young T-cell cancer
This trial tests a combination of three drugs (calaspargase, decitabine, and venetoclax) for children, teens, and young adults with T-cell leukemia or lymphoma that has come back or not responded to treatment. The goal is to see if this combination can help destroy cancer cells.
Houston, TexasAges 1 month–21 years - NCT06560554Enrolling by invitation
Fermented diet for long COVID microbiome health
This study tests whether eating fermented foods (like yogurt, kimchi, or sauerkraut) can improve gut health and ease symptoms in people with long COVID. You'll log your food on your phone and follow a fermented diet for a period of time.
Rochester, MinnesotaAges 18 years+ - NCT05950503Recruiting
MRI to assess liver spread from colon cancer
This trial studies how well MRI can evaluate liver metastases (spread to the liver) from colorectal cancer. If you have measurable liver lesions, your MRI results may help doctors better track and plan care.
RomaAges 18–85 - NCT06207981RecruitingPhase 3
Comparing two treatment plans for advanced anal cancer
This trial tests if giving chemotherapy before standard chemoradiation works better than standard chemoradiation alone for people with locally advanced anal cancer that has not spread. It aims to improve treatment outcomes.
AgenAges 18 years+ - NCT03262259Recruiting
Testing a global smart drinking goals program
This study looks at a “smart drinking goals” program for teens and adults. If it helps, it could guide safer drinking choices and goal-setting in everyday life.
Calverton, MarylandAges 12 years+ - NCT06023069Recruiting
Walking test before surgery and recovery after
This study checks how well you can walk before your planned surgery and whether that affects how quickly you recover afterward.
StockholmAges 18 years+ - NCT06346119Recruiting
Touch relaxation in ICU patients on a breathing machine
This study tests whether gentle touch therapy (like a hand or foot massage) helps reduce stress in patients who are on a breathing machine and sedated in the ICU. The goal is to make the recovery process more comfortable.
NiortAges 18 years+ - NCT06537752Recruiting
Study on symptoms of ethanol in breast cancer patients
This trial checks how breast cancer patients react to ethanol (alcohol) during chemotherapy with docetaxel. It aims to understand side effects and safety for people getting this treatment.
SeoulAges 19 years+ - NCT06541847RecruitingPhase 2
Testing HLX-1502 for NF1 with Plexiform Neurofibromas
This trial tests an experimental drug called HLX-1502 for people with NF1 who have a plexiform neurofibroma (a type of nerve tumor) that is growing or causing problems. It aims to see if the drug is safe and can shrink or stop the tumor from worsening.
Birmingham, AlabamaAges 12 years+ - NCT06542250RecruitingPhase 1/Phase 2
Study of a new immune therapy for relapsed B-cell cancers
This trial tests a new drug (AZD5492) that helps your immune system attack a protein (CD20) on cancer cells. It's for people with B-cell cancers that have come back after at least 2 prior treatments.
La Jolla, CaliforniaAges 18 years+ - NCT06548360RecruitingPhase 3
Testing ruxolitinib cream for children with vitiligo
This study tests a cream called ruxolitinib for children with nonsegmental vitiligo. It aims to see if the cream can safely help restore skin color in affected areas.
Birmingham, AlabamaAges 2–11 - NCT06542237RecruitingPhase 1/Phase 2
Study of a new male birth control pill for healthy men
This trial tests an experimental birth control pill (YCT-529) taken daily. It aims to see if the drug can safely and effectively prevent pregnancy in healthy men who do not plan to have children in the future.
Grafton, AucklandAges 28–70 - NCT06545955RecruitingPhase 3
Gene therapy study for high-grade bladder cancer not responding to BCG
This trial tests a gene therapy called nadofaragene firadenovec, given directly into the bladder, either alone or with chemo or immunotherapy. It's for people with high-grade bladder cancer that hasn't gone away after BCG treatment.
Tucson, ArizonaAges 18 years+ - NCT06547775RecruitingPhase 1
Study of KN069 for people with obesity or overweight
This trial tests a new drug called KN069 to see if it can help people who are overweight or have obesity. It may offer a new treatment option for weight management.
Changsha, HunanAges 18–55 - NCT06549400Enrolling by invitationPhase 3
Study on long-term safety of mexiletine for myotonic dystrophy
This study tests if a daily capsule of mexiletine is safe and helpful over 26 weeks for people with myotonic dystrophy type 1 or 2. It's for people who finished a previous related study and want to continue treatment.
LeuvenAges 16 years+ - NCT06543615Enrolling by invitation
Ultrasound stomach check before surgery in sleeve gastrectomy patients
This study uses ultrasound to measure how much stomach content remains after fasting in people who have had sleeve gastrectomy surgery. It aims to understand if the standard 8-hour fasting period is enough for this group before other surgeries.
Cairo, Cairo GovernorateAges 21–45 - NCT06542757Recruiting
Focused radiation to main prostate tumor using MRI guidance
This trial tests a stronger, more focused radiation dose to the main tumor inside the prostate using MRI guidance. It aims to improve control of intermediate-risk prostate cancer while possibly reducing side effects.
New York, New YorkAges 18 years+ - NCT06539624Recruiting
Testing a new gene therapy for Fabry disease
This trial is testing a new treatment called EXG110 for people with Fabry disease. It's designed to see if it's safe and if it can help. You may be able to join if you have a confirmed diagnosis and at least one symptom of Fabry disease.
Shanghai, Shanghai MunicipalityAges 7 years+ - NCT06538220Recruiting
A study on care for obese patients in a chronic disease unit
This study looks at how well a special care program works for people with obesity. It aims to improve health and quality of life through a dedicated chronic disease unit.
La Garde, VarAges 18 years+ - NCT06538675Enrolling by invitation
Comparing different talk therapies for adults
This study compares different types of talk therapy to see which works best. It is for adults who need psychotherapy and can complete questionnaires in German.
Salzburg, State of SalzburgAges 18–80 - NCT06549231RecruitingPhase 3
Rituximab and mycophenolate for scleroderma lung disease
This trial tests whether combining two drugs, rituximab and mycophenolate mofetil, is safe and works better than standard care for lung scarring caused by scleroderma. It may be an option if your lung disease is severe or getting worse.
ToursAges 18–100 - NCT06544863Recruiting
Better support for cirrhosis and liver transplant patients
This study tests a new care support program for people with cirrhosis or who have had a liver transplant. It aims to improve how patients are followed and helped at the hospital.
ParisAges 18 years+ - NCT06533436Recruiting
Comparing two ways to secure a breathing tube
This study compares two methods of holding a breathing tube in place for patients who are already intubated. The goal is to see which method works better and costs less.
SuresnesAges 18 years+ - NCT03993262RecruitingPhase 2
Bortezomib for severe autoimmune encephalitis after rituximab
This Phase 2 study tests whether bortezomib can improve outcomes and safety in adults with severe autoimmune encephalitis. It focuses on people whose condition is confirmed by brain-related autoantibodies and who have already received rituximab.
München, BavariaAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,241 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.